Journal of Clinical Endocrinology & Metabolism, Vol 75, 714-720, Copyright © 1992 by Endocrine Society

ARTICLES

The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients

NA Samaan, PN Schultz, RC Hickey, H Goepfert, TP Haynie, DA Johnston and NG Ordonez
Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030.

This study analyzed the impact of prognostic variables of age, sex, histopathological diagnosis, extent of disease at diagnosis, and surgical intervention on well differentiated thyroid carcinoma and how surgical treatment, radioactive iodine, and radiotherapy influence the patients' outcomes. There have been 1599 patients with well differentiated thyroid cancer treated and followed at the University of Texas M.D. Anderson Cancer Center from 1948 to 1989. The median follow- up for all patients was 11.0 yr, with the maximum follow-up being 43 yr and the minimum follow-up being 1 yr. The patients were predominantly female (2.3:1), with papillary (81%) and intrathyroidal carcinomas (42%) at the time of diagnosis. Sixty-six percent of the patients had a total thyroidectomy, 7% received external radiotherapy, and 46% had radioactive iodine as part of the treatment of the original disease; the overall recurrence rate was 23%, and the death rate was 11%. This study showed that treatment with radioactive iodine was the single most powerful prognostic indicator for increased disease-free interval (P less than 0.001) and that its use significantly increased survival as well. No benefit was obtained from treatment with external radiotherapy. Children had the best overall survival, but of the adult patients, females who had intrathyroidal papillary disease treated with total thyroidectomy, who had been given radioactive iodine, and whose disease had been diagnosed between 20-59 yr of age had the best prognosis.

This article has been cited by other articles:

				J. S. Park, K.-R. Son, D. G. Na, E. Kim, and S. Kim Performance of Preoperative Sonographic Staging of Papillary Thyroid Carcinoma Based on the Sixth Edition of the AJCC/UICC TNM Classification System Am. J. Roentgenol., January 1, 2009; 192(1): 66 - 72. [Abstract] [Full Text] [PDF]

				I. D. Hay, I. R. McDougall, and J. C. Sisson Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma J. Nucl. Med., August 1, 2008; 49(8): 1395 - 1397. [Abstract] [Full Text] [PDF]

				S. Bardet, E. Malville, J.-P. Rame, E. Babin, G. Samama, D. De Raucourt, J.-J. Michels, Y. Reznik, and M. Henry-Amar Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur. J. Endocrinol., April 1, 2008; 158(4): 551 - 560. [Abstract] [Full Text] [PDF]

				M M Muresan, P Olivier, J Leclere, F Sirveaux, L Brunaud, M Klein, R Zarnegar, and G Weryha Bone metastases from differentiated thyroid carcinoma Endocr. Relat. Cancer, March 1, 2008; 15(1): 37 - 49. [Abstract] [Full Text] [PDF]

				K. Sakano, M. Takahashi, M. Mutoh, N. Niho, M. Komiya, H. Sato, T. Tanaka, T. Sugimura, and K. Wakabayashi Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus Carcinogenesis, October 1, 2007; 28(10): 2193 - 2198. [Abstract] [Full Text] [PDF]

				P. Z. Pace-Asciak, R. J. Payne, S. J. Eski, P. Walfish, M. Damani, and J. L. Freeman Cost Savings of Patients With a MACIS Score Lower Than 6 When Radioactive Iodine Is Not Given Arch Otolaryngol Head Neck Surg, September 1, 2007; 133(9): 870 - 873. [Abstract] [Full Text] [PDF]

				V. Johanson, H. Ahlman, P. Bernhardt, S. Jansson, L. Kolby, F. Persson, G. Stenman, C. Sward, B. Wangberg, M. Stridsberg, et al. A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis Endocr. Relat. Cancer, June 1, 2007; 14(2): 433 - 444. [Abstract] [Full Text] [PDF]

				N. Lee and M. Tuttle The role of external beam radiotherapy in the treatment of papillary thyroid cancer Endocr. Relat. Cancer, December 1, 2006; 13(4): 971 - 977. [Abstract] [Full Text] [PDF]

				H.-Y. Chang, J.-D. Lin, S.-C. Chou, T.-C. Chao, and C. Hsueh Clinical Presentations and Outcomes of Surgical Treatment of Follicular Variant of the Papillary Thyroid Carcinomas Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 688 - 693. [Abstract] [Full Text] [PDF]

				M Niedziela Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453. [Abstract] [Full Text] [PDF]

				P. Siironen, A. Ristimaki, K. Narko, S. Nordling, J. Louhimo, S. Andersson, R. Haapiainen, and C. Haglund VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 465 - 473. [Abstract] [Full Text] [PDF]

				F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J. W A Smit, W. Wiersinga, and the European Thyroid Cancer Taskforce European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol., June 1, 2006; 154(6): 787 - 803. [Full Text] [PDF]

				A. Chiloeches and R. Marais Is BRAF the Achilles' Heel of Thyroid Cancer? Clin. Cancer Res., March 15, 2006; 12(6): 1661 - 1664. [Full Text] [PDF]

				C. F. A. Eustatia-Rutten, E. P. M. Corssmit, N. R. Biermasz, A. M. Pereira, J. A. Romijn, and J. W. Smit Survival and Death Causes in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 313 - 319. [Abstract] [Full Text] [PDF]

				B Jarzab, D Handkiewicz-Junak, and J Wloch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803. [Abstract] [Full Text] [PDF]

				S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D. M. Hartl, J.-M. Bidart, J.-P. Travagli, and M. Schlumberger Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5723 - 5729. [Abstract] [Full Text] [PDF]

				F. A Verburg, B. de Keizer, C. J M Lips, P. M J Zelissen, and J. M H de Klerk Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients Eur. J. Endocrinol., January 1, 2005; 152(1): 33 - 37. [Abstract] [Full Text] [PDF]

				A. Rouxel, G. Hejblum, M.-O. Bernier, P.-Y. Boelle, F. Menegaux, G. Mansour, C. Hoang, A. Aurengo, and L. Leenhardt Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5362 - 5368. [Abstract] [Full Text] [PDF]

				G.-U. Hung, S.-T. Tu, I.-S. Wu, and K.-T. Yang Comparison of the Effectiveness Between a Single Low Dose and Fractionated Doses of Radioiodine in Ablation of Post-operative Thyroid Remnants Jpn. J. Clin. Oncol., August 1, 2004; 34(8): 469 - 471. [Abstract] [Full Text] [PDF]

				A. M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, and H. C. Gerstein A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3668 - 3676. [Abstract] [Full Text] [PDF]

				D. I. Serhal, M. P. Nasrallah, and B. M. Arafah Rapid Rise in Serum Thyrotropin Concentrations after Thyroidectomy or Withdrawal of Suppressive Thyroxine Therapy in Preparation for Radioactive Iodine Administration to Patients with Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3285 - 3289. [Abstract] [Full Text] [PDF]

				C. E. Palme, Z. Waseem, S. N. Raza, S. Eski, P. Walfish, and J. L. Freeman Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma Arch Otolaryngol Head Neck Surg, July 1, 2004; 130(7): 819 - 824. [Abstract] [Full Text] [PDF]

				C. S. Bal, A. Kumar, and G. S. Pant Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1666 - 1673. [Abstract] [Full Text] [PDF]

				Y. Giles, H. Boztepe, T. Terzioglu, and S. Tezelman The Advantage of Total Thyroidectomy to Avoid Reoperation for Incidental Thyroid Cancer in Multinodular Goiter Arch Surg, February 1, 2004; 139(2): 179 - 182. [Abstract] [Full Text] [PDF]

				J. C. Roach, K. S. Heller, S. Dubner, and L. A. Sznyter The Value of Frozen Section Examinations in Determining the Extent of Thyroid Surgery in Patients With Indeterminate Fine-Needle Aspiration Cytology Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 263 - 267. [Abstract] [Full Text] [PDF]

				Y. Kitamura, K. Shimizu, K. Ito, S. Tanaka, and M. Emi Allelotyping of Follicular Thyroid Carcinoma: Frequent Allelic Losses in Chromosome Arms 7q, 11p, and 22q J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4268 - 4272. [Abstract] [Full Text] [PDF]

				K. Ohta, T. Endo, K. Haraguchi, J. M. Hershman, and T. Onaya Ligands for Peroxisome Proliferator-Activated Receptor {{gamma}} Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2170 - 2177. [Abstract] [Full Text]

				R. Solans, J.-A. Bosch, P. Galofré, F. Porta, J. Roselló, A. Selva-O’Callagan, and M. Vilardell Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy J. Nucl. Med., May 1, 2001; 42(5): 738 - 743. [Abstract] [Full Text]

				E. L. Mazzaferri and R. T. Kloos Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1447 - 1463. [Full Text]

				S. A. R. Doi Usefulness of the Diagnostic Total Body Scan in Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 949 - 949. [Full Text]

				S. Hoelzer, A. M. Fremgen, A. Stewart, C. Reiners, and J. Dudeck Evaluating the Implications of Clinical Practice Guidelines for Patient Care American Journal of Medical Quality, January 1, 2001; 16(1): 9 - 16. [Abstract] [PDF]

				Y. Kitamura, K. Shimizu, S. Tanaka, K. Ito, and M. Emi Association of Allelic Loss on 1q, 4p, 7q, 9p, 9q, and 16q with Postoperative Death in Papillary Thyroid Carcinoma Clin. Cancer Res., May 1, 2000; 6(5): 1819 - 1825. [Abstract] [Full Text] [PDF]

				S. O. Sebastian, J. M. R. Gonzalez, P. P. Paricio, J. S. Perez, D. P. Flores, A. P. Madrona, P. R. Romero, and F. J. Tebar Papillary Thyroid Carcinoma: Prognostic Index for Survival Including the Histological Variety Arch Surg, March 1, 2000; 135(3): 272 - 277. [Abstract] [Full Text] [PDF]

				A. F. Cailleux, E. Baudin, J. P. Travagli, M. Ricard, and M. Schlumberger Is Diagnostic Iodine-131 Scanning Useful after Total Thyroid Ablation for Differentiated Thyroid Cancer? J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 175 - 178. [Abstract] [Full Text]

				Y. Kitamura, K. Shimizu, M. Nagahama, K. Sugino, O. Ozaki, T. Mimura, K. Ito, K. Ito, and S. Tanaka Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4043 - 4049. [Abstract] [Full Text]

				L. Wartofsky Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4195 - 4199. [Full Text]

				M. Schlumberger Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer: Towards A Selective Approach J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4201 - 4203. [Full Text]

				H. Yamashita, S. Noguchi, H. Yamashita, N. Murakami, S. Watanabe, S. Uchino, H. Kawamoto, M. Toda, and I. Nakayama Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer Arch Surg, October 1, 1998; 133(10): 1058 - 1065. [Abstract] [Full Text] [PDF]

				S. Noguchi, N. Murakami, H. Yamashita, M. Toda, and H. Kawamoto Papillary Thyroid Carcinoma: Modified Radical Neck Dissection Improves Prognosis Arch Surg, March 1, 1998; 133(3): 276 - 280. [Abstract] [Full Text] [PDF]

				P. R. Kelemen, A. J. Van Herle, and A. E. Giuliano Sentinel Lymphadenectomy in Thyroid Malignant Neoplasms Arch Surg, March 1, 1998; 133(3): 288 - 292. [Abstract] [Full Text] [PDF]

				M. J. Schlumberger Papillary and Follicular Thyroid Carcinoma N. Engl. J. Med., January 29, 1998; 338(5): 297 - 306. [Full Text] [PDF]

				A. C. Chiu, E. S. Delpassand, and S. I. Sherman Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3637 - 3642. [Abstract] [Full Text] [PDF]